Detection of tumor messenger RNA in the serum of patients with malignant melanoma

Clinical Cancer Research

Volumn 5, Issue 8, 1999, Pages 1961-1965

  Kopreski, Michael S ^a,d   Benko, Floyd A ^c   Kwak, Larry W ^b   Gocke, Christopher D ^a,c  

^a OncoMEDx Inc   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RIBONUCLEASE;

ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; GEL ELECTROPHORESIS; GENE AMPLIFICATION; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BLOTTING, SOUTHERN; ELECTROPHORESIS, AGAR GEL; FREEZING; HUMANS; MELANOMA; MONOPHENOL MONOOXYGENASE; PREDICTIVE VALUE OF TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SENSITIVITY AND SPECIFICITY;

EID: 0032802166     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Datta, Y. H., Adams, P. T., Drobyski, W. R., Ethier, S. P., Terry, V. H., and Roth, M. S. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J. Clin. Oncol., 12: 475-482, 1994.
2. Moreno, J. G., Croce, C. M., Fischer, R., Monne, M., Vihko, P., Mulholland, S. G., and Gomella, L. G. Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res., 52: 6110-6112, 1992.
3. Smith, B., Selby, P., Southgate, J., Pittman, K., Bradley, C., and Blair, G. E. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet, 338: 1227-1229, 1991.
4. Brossart, P., Keilholz, U., Scheibenbogen, C., Mohler, T., Willhauck, M., and Hunstein, W. Detection of residual tumor cells in patients with malignant melanoma responding to immunotherapy. J. Immunother., 15: 38-41, 1994.
5. Hardingham, J. E., Kotasek, D., Sage, R. E., Eaton, M. C., Pascoe, V. H., and Dobrovic, A. Detection of circulating tumor cells in colorectal cancer by immunobead-PCR is a sensitive prognostic marker for relapse of disease. Mol. Med., 1: 789-794, 1995.
6. Glaser, R., Rass, K., Seiter, S., Hauschild, A., Christophers, E., and Tilgen, W. Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: a clinical two-center study. J. Clin. Oncol., 15: 2818-2825, 1997.
7. Farthmann, B., Eberle, J., Krasagakis, K., Gstottner, M., Wang, N., Bisson, S., and Orfanos, C. E. RT-PCR for tyrosinase-mRNA-positive cells in peripheral blood: evaluation strategy and correlation with known prognostic markers in 123 melanoma patients. J. Invest. Dermatol., 110: 263-267, 1998.
8. Reinhold, U., Ludtke-Handjery, H. C., Schnautz, S., Kreysel, H. W., and Abken, H. The analysis of tyrosinase-specific mRNA in blood samples of melanoma patients by RT-PCR is not a useful test for metastatic tumor progression. J. Invest. Dermatol., 108: 166-169, 1997.
9. Sorenson, G. D., Pribish, D. M., Valone, F. H., Memoli, V. A., Bzik, D. J., and Yao, S-L. Soluble normal and mutated DNA sequences from single-copy genes in human blood. Cancer Epidemiol. Biomark. Prev., 3: 67-71, 1994.
10. Kopreski, M. S., Benko, F. A., Kwee, C., Leitzel, K. E., Eskander, E., Lipton, A., and Gocke, C. D. Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer. Br. J. Cancer, 76: 1293-1299, 1997.
11. Vasioukhin, V., Anker, P., Maurice, P., Lyautey, J., Lederrey, C., and Stroun, M. Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia. Br. J. Haematol., 86: 774-779, 1994.
12. Anker, P., Lefort, F., Vasioukhin, V., Lyautey, J., Lederrey, C., Chen, X. Q., Stroun, M., Mulcahy, H. E., and Farthing, M. J. G. K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology, 112: 1114-1120, 1997.
13. Chen, X. Q., Stroun, M., Magnenat, J-L., Nicod, L. P., Kurt, A-M., Lyautey, J., Lederrey, C., and Anker, P. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat. Med., 9: 1033-1035, 1996.
14. Nawroz, H., Koch, W., Anker, P., Stroun, M., and Sidransky, D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat. Med., 9: 1035-1037, 1996.
15. Hibi, K., Robinson, C. R., Booker, S., Wu, L., Hamilton, S. R., Sidransky, D., and Jen, J. Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res., 58: 1405-1407, 1998.
16. Kopreski, M. S., Benko, F. A., Borys, D. J., Khan, A., Kwee, C. M., McGarrity, T. J., and Gocke, C. D. Mutated KRAS DNA in plasma as a marker in early colorectal neoplasia. Proc. Am. Soc. Clin. Oncol., 17: 269, 1998.
17. Mulcahy, H. E., Lyautey, J., Lederrey, C., Chen, X. Q., Anker, P., Alstead, E. M., Ballinger, A., Farthing, M. J. G., and Stroun, M. A prospective study of K-ras mutations in the plasma of pancreatic cancer patients. Clin. Cancer Res., 4: 271-275, 1998.
18. Reddi, K. K., and Holland, J. F. Elevated serum ribonuclease in patients with pancreatic cancer. Proc. Natl. Acad. Sci. USA, 73: 2308-2310, 1976.
19. Kamm, R. C., and Smith, A. G. Nucleic acid concentrations in normal human plasma. Clin. Chem., 18: 519-522, 1972.
20. Mountford, C. E., May, G. L., Wright, L. C., MacKinnon, W. B., Dyne, M., Holmes, K. T., Van Haaften-Day, C., and Tattersall, M. H. N. Proteolipid identified by magnetic resonance spectroscopy in plasma of a patient with borderline ovarian tumour. Lancet, 1: 829-834, 1987.
21. Wieczorek, A. J., Rhyner, C., and Block, L. H. Isolation and characterization of an RNA-proteolipid complex associated with the malignant state in humans. Proc. Natl. Acad. Sci. USA, 82: 3455-3459, 1985.
22. Wieczorek, A. J., Sitaramam, V., Machleidt, W., Rhyner, K., Perruchoud, A. P., and Block, L. H. Diagnostic and prognostic value of RNA-proteolipid in sera of patients with malignant disorders following therapy: first clinical evaluation of a novel tumor marker. Cancer Res., 47: 6407-6412, 1987.
23. Kawasaki, E. S. Amplification of RNA. In: M. A. Innis, D. H. Gelfand, J. J. Sninsky, and T. J. White (eds.), PCR Protocols: A Guide to Methods and Applications, pp. 23-27. San Diego: Academic Press, 1990.
24. Komeda, T., Fukuda, Y., Sando, T., Kita, R., Furukawa, M., Nishida, N., Amenomori, M., and Nakao, K. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer (Phila.), 75: 2214-2219, 1995.
25. Juckett, D. A., and Rosenberg, B. Actions of cis-diamminedichloroplatinum on cell surface nucleic acids in cancer cells as determined by cell electrophoresis techniques. Cancer Res., 42: 3565-3573, 1982.
26. Rieber, M., and Bacalao, J. An "external" RNA removable from mammalian cells by mild proteolysis. Proc. Natl. Acad. Sci. USA, 71: 4960-4964, 1974.
27. Barz, D., Goppelt, M., Szamel, M., Schirrmacher, V., and Resch, K. Characterization of cellular and extracellular plasma membrane vesicles from a non-metastasing lymphoma (Eb) and its metastasing variant (Esb). Biochim. Biophys. Acta, 814: 77-84, 1985.
28. Carr, J. M., Dvorak, A. M., and Dvorak, H. F. Circulating membrane vesicles in leukeinic blood. Cancer Res., 45: 5944-5951, 1985.
29. Rosi, A., Guidoni, L., Luciani, A. M., Mariutti, G., and Viti, V. RNA-lipid complexes released from the plasma membrane of human colon carcinoma cells. Cancer Lett., 39: 153-160, 1988.
30. Masella, R., Cantafora, A., Guidoni, L., Luciani, A. M., Mariutti, G., Rosi, A., and Viti, V. Characterization of vesicles, containing an acylated oligopeptide, released by human colon adenocarcinoma cells. FEES Lett, 246: 25-29, 1989.
31. Stroun, M., Anker, P., Beljanski, M., Henri, J., Lederrey, C., Ojha, M., and Maurice, P. A. Presence of RNA in the nucleoprotein complex spontaneously released by human lymphocytes and frog auricles in culture. Cancer Res., 38: 3546-3554, 1978.
32. Rosenberg-Nicolson, N. L., and Nicolson, G. L. Nucleoprotein complexes released from lymphoma nuclei that contain the abl oncogene and RNA and DNA polymerase and RNA primase activities. J. Cell. Biochem., 50: 43-52, 1992.